News

Arlington, VA, Feb. 9 – The Consumer Technology Association (CTA)® and the American College of Cardiology (ACC) today announced the first-ever industry framework to evaluate and give guidance for consumer devices or applications designed...

Phase 2a clinical trial evaluating REG-101 for PAD expected to initiate second half of 2022

Researchers focused on multiple aspects of sleep health, such as regularity, satisfaction, alertness during waking hours, timing of sleep, sleep efficiency and sleep duration and linked them to physician-diagnosed heart disease. They found...

A recent study in CJASN that analyzes data from the Veterans Health Administration has revealed a high rate of deaths associated AKI, as more than 1 in 4 patients with AKI died within 1 year of hospitalization.

SUNNYVALE, CALIF. – February 3, 2022 – BioCardia®, Inc., a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, announced that the U.S. Food and Drug Administration (FDA) has...

The Health eBrain Study, published in JMIR Formative Research, enrolled and assessed 239 older adults in a proof-of-concept trial to determine if novel, remotely-administered, cognitive assessments could detect the known association between...

Abbott’s investigational Aveir™ DR dual-chamber pacemaker is designed to provide synchronous, beat-by-beat pacing of the right atrium and right ventricle of the heart

February 4, 2022, WASHINGTON – A newly released expert consensus statement on sex-specific considerations in myocardial revascularization aims to summarize available literature on myocardial revascularization in women and identify important...

February 2, 2022 — A graft can be a life-saving device for coronary heart disease, which remains the leading cause of death for both men and women in the United States. However, at small diameters — such as the coronary artery in the heart —...